Denville-based Katena said in a news release that the deal for the Florida-based company bolsters its offerings in the anterior segment surgical business.
“The acquisition of the Rhein Medical product line is an important addition to Katena’s product portfolio,” CEO Mark Fletcher said in a prepared statement. “The combination of these two renowned brands will bring internal synergies as well as offer physicians a more complete resource for handheld instrumentation.”
The 30-year-old Rhein makes devices for cataract and refractive surgery, glaucoma and corneal procedures and more, Katena added.
“Having dedicated ourselves to producing the finest-quality instruments possible, we are confident that our legacy of quality will continue under Katena,” John Bee, Rhein’s president, said in a statement.
Katena is a unit of Audax Private Equity, based in Boston.